Is the Cochlear (ASX:COH) share price a long term market beater?

Could the Cochlear Limited (ASX:COH) share price be a long term market beater?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

According to the United Nations, the global population aged 60 years stood at approximately 962 million in 2017.

This was more than twice as large as in 1980 when there were 382 million older persons worldwide.

The intergovernmental organisation is now expecting this figure to more than double again by 2050. At this point, it is projecting that the global population aged 60 years will reach almost 2.1 billion.

This population shift is widely expected to lead to increased demand for healthcare services over the next three decades. Which could be great news for Australian healthcare shares.

One that has been tipped as a big winner from this tailwind is Cochlear Limited (ASX: COH).

Why Cochlear?

Cochlear is a leading global hearing solutions company. It manufactures some of the highest quality and most popular cochlear implant hearing devices in the world.

While 2020 has been a difficult year because of the pandemic's impact on elective surgeries, a recent update appears to demonstrate that the worst is now over for the company. Furthermore, with potentially effective COVID-19 vaccines not far away, 2021 looks set to be a significantly better year for Cochlear.

Looking further ahead, the expected increase in the over-60 population over the coming decades will be good news for Cochlear. This is because as people age, their hearing will invariably fade and require some form of assistance.

One broker that is positive on the company is Macquarie. It recently put an outperform rating and $241.00 price target on the company's shares. Its research appears to show that Cochlear has been winning market share.

In addition to this, its survey of US audiologists shows that its products are the most highly rated in the industry. The broker feels this bodes well as activity levels recover from the COVID disruption.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ ASX Shares

a woman wearing a close-sitting hat featuring wires and thick computer screen glasses clutches her computer monitor and looks shocked and disturbed as she reads old-fashioned computer text from the screen.
Technology Shares

Here's why ASX 200 tech shares (ASX:XTX) outperformed today

ASX tech shares have taken a turn for the better today.

Read more »

Worker in hard hat looks puzzled with one hand on chin
Resources Shares

Why did the Rio Tinto share price (ASX:RIO) have such a lousy 2021?

We look at what happened to this ASX 200 mining giant's shares last year

Read more »

a miner wearing a hard hat smiles as he stands in front of heavy earth moving equipment on a barren mine site.
Share Gainers

Here's why the Rumble Resources (ASX:RTR) share price is climbing 5%

The mineral explorer's share price is on the rise amid promising drill results.

Read more »

share price high, all time record, record share price, highest, price rise, increase, up,
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Wednesday

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

comical investor reading documents and surrounded by calculators
⏸️ ASX Shares

The ASX reporting wrap-up: WiseTech, Bravura, Seven Group

Just what the investor ordered. Here’s a recap of the companies that reported on Wednesday...

Read more »

Doctor performing an ultrasound on pregnant woman
⏸️ ASX Shares

The ASX reporting wrap-up: Ansell, Kogan, Nanosonics

Just what the investor ordered. Here’s a recap of the companies that reported on Tuesday...

Read more »

blue arrows representing a rising share price ASX 200
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Tuesday

Here are your top 10 biggest gainers in the ASX 200 on Tuesday.

Read more »

unhappy investor considering computer screen
Share Market News

The ASX reporting wrap-up: Charter Hall, Ampol, NIB Holdings

Just what the investor ordered. Here’s a recap of the companies that reported on Monday...

Read more »